LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today announced dosing of the...

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates NAIROBI, Kenya, Jan. 25, 2024 /PRNewswire/...

In a strategic move within Alphabet, Isomorphic, the brainchild of Google DeepMind, has successfully sealed two substantial pharmaceutical agreements with industry giants Eli Lilly...

This year, the Physics World team selected a medical innovation as the Breakthrough of the Year: the development of a digital bridge that restores...

Can Cannabis Complement Functional and Alternative Medicine? Modern medicine has failed us, big time. The very doctors who are supposed to heal us, instead focus on...

Siemens Healthineers explains how bringing more innovation on the imaging as well as the treatment side can enhance patient outcomes In this short video, filmed...

. Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“CL”) for breast cancer medications,...

After open public discussion and a unanimous board vote, Tri-City Healthcare District (“Tri-City” or “District”) announced yesterday that UC San Diego Health has been...

Penn's oncology care clinicians will have access to Flatiron Assist's clinical decision support Earlier this week, Flatiron Health, a a healthcare technology and...

A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...

September 20, 2023, by Elia Ben-Ari A team of US and Australian scientists has...